- ALK -1.20%
Alaska Air Group (ALK) Stock Slides as Market Rises: Facts to Know Before You Trade
Yahoo Finance · 8 hours ago
Search results
- 41.01Add to watchlist-0.50 (-1.20%)At close: Thu. Jun 13, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open41.42High41.42Low40.44
- Mkt Cap5.2BP/E (TTM)21.70Div & YieldN/A & N/A
- Prev. Close41.5152 Wk. Low30.7552 Wk. High57.18
Top storiesRelated stocks
ALK is a global pharmaceutical company focusing on allergy treatment and diagnosis. Learn more about ALK. WHAT WE DO. ALK is devoted to being there for people with allergies by developing pharmaceutical products that target the actual cause of allergy. Read more about what we do. OUR MILESTONES.
Find the latest Alaska Air Group, Inc. (ALK) stock quote, history, news and other vital information to help you with your stock trading and investing.
Mar 4, 2024 · Since 1923, we have consistently devised and developed major advances for the treatment of allergy. In recent years, we have invested substantially in the research and development of new, evidence-based allergy immunotherapy treatments. Read more about ALK's history.
Nov 17, 2022 · ALK stands for anaplastic lymphoma kinase. It was originally described in lymphoma, but most ALK-positive cancers are in non-small cell lung cancer. The ALK gene is in your body when you are an embryo. It helps in the development of the gut and nervous system.
Jan 27, 2021 · The anaplastic lymphoma kinase (ALK) mutation is one of those gene changes. Knowing whether your cancer is ALK positive can help your doctor figure out which treatments will work best...
3 days ago · ALK | Complete Alaska Air Group Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Aug 30, 2019 · ALK is a global, research-driven pharmaceutical company that focuses on the prevention, diagnosis and treatment of allergies. OUR HISTORY. Nearly a century of leadership in allergy immunotherapy. Read more about ALK's rich history. OUR MILESTONES. Since 1923, we have consistently devised and developed major advances for the treatment of allergy.
